MoonLake Immunotherapeutics AG ("MoonLake"), a clinical-stage biotechnology company focused on creating next-level therapies for inflammatory diseases, announced that it is proceeding with a global...
LogicBio® Therapeutics, Inc. , a clinical-stage genetic medicine company, announced that president and chief executive officer, Frederic Chereau, will present a company overview at...
Imbria Pharmaceuticals, Inc., a clinical stage, cardio-metabolic company developing novel therapies designed to enhance cellular energetics, announced that Anne Prener, president and chief executive...
VivaVision Biotech, Inc., an ophthalmic pharmaceutical developer focusing on discovery and development of innovative therapies for ocular diseases, announced positive topline results from a...
Curative Biotechnology, Inc., a development-stage biomedical company focused on novel treatments for rare diseases and conditions, announced today a Cooperative Research and Development Agreement...
